Clinical evaluation of the Hydra self‐expanding transcatheter aortic valve: 6 month results from the GENESIS trial

202111 citationsJournal Article

Authors

Praveen Chandra · Medanta The Medicity

John Jose · Christian Medical College, Vellore

Shafeeq Mattummal · ASTER

Ajaykumar Umakant Mahajan · Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College

Sajeev Chakanalil Govindan · Government Medical College

Chandrashekhar Makhale · Ruby Hall Clinic

Sharad Chandra

Abstract

The GENESIS trial demonstrated high efficacy of the self-expanding Hydra THV. The cardiovascular mortality rate of 7.5% may partly be explained by the inclusion of some centres with no or limited previous experience in transcatheter aortic valve implantation.

Topics & Keywords

Cardiac Valve Diseases and Treatments Cardiac electrophysiology and arrhythmias Cardiovascular Function and Risk Factors

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Catheterization and Cardiovascular Interventions

Volume 98, Issue 2, pp. 371-379

DOI: 10.1002/ccd.29733

Field-Weighted Citation Impact: 1.10